Nicola Martini

Dr. Nicola Martini

Fondazione Toscana Gabriele Monasterio, Pisa, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in NeuroImage
Verified
Journal Article
Closed access
NMNicola Martini
Nicola Martini
Danilo MenicucciDanilo Menicucci
Danilo Menicucci
SLSebastiani Laura
Sebastiani Laura
RBRemo Bedini
Remo Bedini
APAlessandro Pingitore
Alessandro Pingitore
AGAngelo Gemignani
Angelo Gemignani

1 March 2018 in Computers & Fluids
Verified
Journal Article
Closed access
ABA. Boccadifuoco
A. Boccadifuoco
Alessandro MariottiAlessandro Mariotti
Alessandro Mariotti
Simona CeliSimona Celi
Simona Celi
NMNicola Martini
Nicola Martini
MSMaria Vittoria Salvetti
Maria Vittoria Salvetti

1 January 2020 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
NMNicola Martini
Nicola Martini
AAAlberto Aimo
Alberto Aimo
ABAndrea Barison
Andrea Barison
DLDaniele Della Latta
Daniele Della Latta
GVGiuseppe Vergaro
Giuseppe Vergaro
DCDante Chiappino
Dante Chiappino
Cardiovascular magnetic resonance (CMR) is part of the diagnostic work-up for cardiac amyloidosis (CA). Deep learning (DL) is an application of artificial intelligence that may allow to automatically analyze CMR findings and establish the likelihood of CA. 1.5 T CMR was performed in 206 subjects with suspected CA (n = 100, 49% with unexplained left ventricular (LV) hypertrophy; n = 106, 51% with blood dyscrasia and suspected light-chain amyloidosis). Patients were randomly assigned to the training (n = 134, 65%), validation (n = 30, 15%), and testing subgroups (n = 42, 20%). Short axis, 2-chamber, 4-chamber late gadolinium enhancement (LGE) images were evaluated by 3 networks (DL algorithms). The tags “amyloidosis present” or “absent” were attributed when the average probability of CA from the 3 networks was ≥ 50% or < 50%, respectively. The DL strategy was compared to a machine learning (ML) algorithm considering all manually extracted features (LV volumes, mass and function, LGE pattern, early blood-pool darkening, pericardial and pleural effusion, etc.), to reproduce exam reading by an experienced operator. The DL strategy displayed good diagnostic accuracy (88%), with an area under the curve (AUC) of 0.982. The precision (positive predictive value), recall score (sensitivity), and F1 score (a measure of test accuracy) were 83%, 95%, and 89% respectively. A ML algorithm considering all CMR features had a similar diagnostic yield to DL strategy (AUC 0.952 vs. 0.982; p = 0.39). A DL approach evaluating LGE acquisitions displayed a similar diagnostic performance for CA to a ML-based approach, which simulates CMR reading by experienced operators.

7 December 2007 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
MMM. Milanesi
M. Milanesi
NMNicola Martini
Nicola Martini
NVN. Vanello
N. Vanello
Vincenzo PositanoVincenzo Positano
Vincenzo Positano
Maria Filomena SantarelliMaria Filomena Santarelli
Maria Filomena Santarelli
Luigi LandiniLuigi Landini
Luigi Landini

9 April 2019 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
GVGabriele Valvano
Gabriele Valvano
GSGianmarco Santini
Gianmarco Santini
NMNicola Martini
Nicola Martini
ARAndrea Ripoli
Andrea Ripoli
CIChiara Iacconi
Chiara Iacconi
DLDaniele Della Latta
Daniele Della Latta
Cluster of microcalcifications can be an early sign of breast cancer. In this paper, we propose a novel approach based on convolutional neural networks for the detection and segmentation of microcalcification clusters. In this work, we used 283 mammograms to train and validate our model, obtaining an accuracy of 99.99% on microcalcification detection and a false positive rate of 0.005%. Our results show how deep learning could be an effective tool to effectively support radiologists during mammograms examination.

13 September 2017 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Simona CeliSimona Celi
Simona Celi
NMNicola Martini
Nicola Martini
LPLuigi Emilio Pastormerlo
Luigi Emilio Pastormerlo
Vincenzo PositanoVincenzo Positano
Vincenzo Positano
SBSergio Berti
Sergio Berti
Background: In the last decades, interventional cardiology has received fast and wide implementation as an effective alternative treatment to surgery for several congenital and acquired diseases. In this scenario, imaging provides solutions for most clinical needs, from diagnosis to prognosis and risk stratification, as well as anatomical and functional assessment. Methods: In this review article, we present recent innovations in medical imaging for structural heart disease and coronary artery disease, emphasizing the progress achieved in the field of multimodality imaging and the solutions proposed to some as-yet unresolved technical problems for safe and effective procedural performance. Results: Intra-procedural guidance can be facilitated by established multimodality cardiac imaging such as transesophageal 2D and 3D echocardiography and by novel techniques as echo-fluoroscopy overlay and 3D modeling/printing. Computed tomography and magnetic resonance imaging are particularly helpful for preprocedural morphology assessment and device sizing. Conclusion: Successful planning, performance, and aftercare of interventions depend heavily on accurate imaging for both structural heart disease and coronary artery disease.